World Generic Medicines Europe Congress attracts attendees from leading generic pharma manufacturers, investment banks, pharmaceutical wholesale, law firms and API manufacturers to discuss the latest developments in the generics industry.
World Generic Medicines Congress Europe 2012
Home/Conferences
|
Posted 27/01/2012
0
Post your comment
World Generics Medicines Congress Europe 2012
28 February–2 March 2012
London, UK
For more information, see:
http://www.healthnetworkcommunications.com/2012/world-generic-medicines-congress-europe/
Guidelines
Advances in EMA plans to streamline biosimilar assessment
FDA issues guidance on AI use in drug and biologicals regulatory decision making
Policies & Legislation
ANVISA and Danish Medicines Agency renew health regulatory collaboration
Colombia and Brazil introduce reforms to enhance healthcare regulation
Related content
ASBM/GaBI 2024 webinar on BIOSIMILAR RED TAPE ELIMINATION ACT (S2305)
Home/Conferences Posted 05/11/2024
ASBM/GaBI 2023 webinar on INTERCHANGEABILITY DESIGNATION FOR BIOSIMILARS
Home/Conferences Posted 12/12/2023
Most viewed articles
The best selling biotechnology drugs of 2008: the next biosimilars targets
Post your comment